PCV47 ROSUVASTATIN 40MG VERSUS ATORVASTATIN 80MG IN HIGH-RISK PATIENTS WITH HYPERCHOLESTEROLAEMIA- ECONOMIC ANALYSIS OF THE POLARIS STUDY

Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67458-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)67458-X/fulltext
Title : PCV47 ROSUVASTATIN 40MG VERSUS ATORVASTATIN 80MG IN HIGH-RISK PATIENTS WITH HYPERCHOLESTEROLAEMIA- ECONOMIC ANALYSIS OF THE POLARIS STUDY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67458-X&doi=10.1016/S1098-3015(10)67458-X
First page :
Section Title :
Open access? : No
Section Order : 23
Categories :
Tags :
Regions :
ViH Article Tags :